The retrospective study looked at 3,340 patients with cardiac surgery and in-hospital outcomes of postoperative mortality, new acute renal failure and perioperative blood transfusion.
Patients who received aprotinin were more often elderly and female. In-hospital mortality was significantly higher in the aprotinin group compared to the TXA group, up 5 percent. The ICU stay was also significantly increased in the aprotinin group, up 8.3 percent.
More Articles on Anesthesia:
Mazzetti, Anesthetic Gas Reclamation Strive to Recapture Anesthetic Gas in Hospitals
Congress Examines Anesthesiologist Exemption to Meaningful Use
Hurricane Sandy Exacerbates Propofol Shortage
